总时间（秒）：10.99
问答时间（秒）：9.02

```json
{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_001183882.2:c.1699C>T",
                    "cDNA Change": {
                        "transcript": "NM_001183882.2",
                        "ref": "C",
                        "alt": "T",
                        "position": "1699"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "Y",
                        "position": "1699"
                    },
                    "Description in input context": "Y1699C to Y1699T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson’s Disease",
        "MONDO": "MONDO:0000327"
    },
    "Experiment Method": [
        {
            "Assay Method": "Cell Viability Assay",
            "Material used": {
                "Material Source": "HEK293 cells",
                "Material Name": "HEK293",
                "Description": "The experiment was conducted using the HEK293 cell line."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_001183882.2:c.1699C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Loss-of-function",
                    "Result Description": "Y1699C and G2019S mutants resulted in a loss of basal cell viability in SH-SY5Y cells, demonstrating innate toxicity.",
                    "Protein Change": {
                        "ref": "R",
                        "alt": "Y",
                        "position": "1699"
                    }
                }
            ],
            "Biological replicates": {
                "Biological replicates": "No",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "No",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "No",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "No",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes",
                "Description": "Cell viability assays are routinely used for studying neurodegenerative diseases."
            }
        }
    ]
}
```